» Articles » PMID: 37698533

Galectin-3 Promotes Brain Injury by Modulating the Phenotype of Microglia Via Binding TLR-4 After Intracerebral Hemorrhage

Overview
Specialty Geriatrics
Date 2023 Sep 12
PMID 37698533
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Intracerebral hemorrhage (ICH) is a stroke subtype with high mortality and disability rate, and neuroinflammation is involved in secondary brain injury. Galectin-3 (Gal-3) is one of the scaffold proteins of Galectins. Studies have indicated that Gal-3 plays an important role in the physiological and pathological state of the nervous system. Here we focus on the role of Gal-3 in ICH, especially in neuroinflammation.

Methods: Injection of autologous blood into the right basal ganglia was used to simulate ICH injury, and the level of Gal-3 in brain was regulated by related means. The changes of Gal-3 were detected by western blot and immunofluorescence, the level of neuroinflammation by immunofluorescence staining and ELISA. Apoptosis and neuron loss were detected by TUNEL staining FJB staining and Nissl staining, and neurological deficits were judged by neurobehavioral tests.

Results: The protein level of Gal-3 increased at 24 h after ICH. Downregulation of Gal-3 level can reduce the infiltration of M1-type microglia and peripheral inflammatory cells, thus alleviating post-ICH neuroinflammation, and reducing cell apoptosis and neuron loss in brain tissue. ICH-induced neurological damage was rescued. Meanwhile, the promotion in the expression level of Gal-3 increased neuroinflammatory activation and nerve cell death, aggravating ICH-induced brain injury.

Conclusions: This study proves that Gal-3 is involved in neuroinflammation and nerve damage after ICH. Gal-3 expression should not be encouraged early on to prevent neuroinflammation. which provides a new possibility for clinical treatment for ICH patients.

Citing Articles

miRNA506 Activates Sphk1 Binding with Sirt1 to Inhibit Brain Injury After Intracerebral Hemorrhage via PI3K/AKT Signaling Pathway.

Liang T, Liu R, Liu J, Hong J, Gong F, Yang X Mol Neurobiol. 2024; 62(4):4093-4114.

PMID: 39395147 DOI: 10.1007/s12035-024-04534-5.


Disulfiram attenuates cell and tissue damage and blood‒brain barrier dysfunction after intracranial haemorrhage by inhibiting the classical pyroptosis pathway.

Xu C, Jiang F, Mao Y, Wei W, Song J, Jia F Sci Rep. 2024; 14(1):21860.

PMID: 39300102 PMC: 11413208. DOI: 10.1038/s41598-024-67118-2.

References
1.
Chen F, Wu X, Yang J, Yu X, Liu B, Yan Z . Hippocampal Galectin-3 knockdown alleviates lipopolysaccharide-induced neurotoxicity and cognitive deficits by inhibiting TLR4/NF-кB signaling in aged mice. Eur J Pharmacol. 2022; 936:175360. DOI: 10.1016/j.ejphar.2022.175360. View

2.
Yu L . Circulating galectin-3 in the bloodstream: An emerging promoter of cancer metastasis. World J Gastrointest Oncol. 2010; 2(4):177-80. PMC: 2999182. DOI: 10.4251/wjgo.v2.i4.177. View

3.
Yang Z, Liu B, Zhong L, Shen H, Lin C, Lin L . Toll-like receptor-4-mediated autophagy contributes to microglial activation and inflammatory injury in mouse models of intracerebral haemorrhage. Neuropathol Appl Neurobiol. 2014; 41(4):e95-106. DOI: 10.1111/nan.12177. View

4.
Sharma U, Pokharel S, van Brakel T, van Berlo J, Cleutjens J, Schroen B . Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation. 2004; 110(19):3121-8. DOI: 10.1161/01.CIR.0000147181.65298.4D. View

5.
Ren Z, Liang W, Sheng J, Xun C, Xu T, Cao R . Gal-3 is a potential biomarker for spinal cord injury and Gal-3 deficiency attenuates neuroinflammation through ROS/TXNIP/NLRP3 signaling pathway. Biosci Rep. 2019; 39(12). PMC: 6923351. DOI: 10.1042/BSR20192368. View